Judge To Consider Class In Pfizer's Neurontin Cases
Law360 (January 23, 2007, 12:00 AM EST) -- Nearly three years after criminal charges were settled in Pfizer Inc.’s illegal marketing of the epilepsy drug Neurontin, a federal judge is considering whether or not to grant class action status...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
